V. T. Perchyonok et al. / Open Journal of Stomatology 3 (2013) 22-30
Copyright © 2013 SciRes.
30
OPEN ACCESS
[3] Imazato, S., Kinomoto, Y., Tarumi, H., Torii, M., Russell,
R.R.B. and McCabe, J.F. (1997) Incorporation of anti-
bacterial monomer MDPB into dentin primer. Journal of
Dental Research, 76, 768-772.
http://dx.doi.org/10.1177/00220345970760030901
[4] Buonocore, M.G. (1955) A simple method of increasing
the adhesion of acrylic filling materials to enamel sur-
faces. Journal of Dental Research, 34, 849-853.
http://dx.doi.org/10.1177/00220345550340060801
[5] Chandler, H.H., Bowen, R.L., Paffenbarger, G.C. and
Mullineaux, A.L. (1970) Clinical investigation of a ra-
diopaque composite restorative material. The Journal of
the American Dental Association, 81, 935-940.
[6] Dorminey, J.C., Dunn, W.J. and Taloumis, L.J. (2003)
Shear bond strength of orthodontic brackets bonded with
a modified 1-step etchant-and-primer technique. Ameri-
can Journal of Orthodontics & Dentofacial Orthopedics,
124, 410-413.
http://dx.doi.org/10.1016/S0889-5406(03)00404-9
[7] Perchyonok, V.T., Zhang, S. and Oberholzer, T. (2013)
Protective effect of conventional antioxidant (β-carotene,
resveratrol and vitamin E) in chitosan-containing hydro-
gels against oxidative stress and reversal of DNA double
stranded breaks induced by common dental composites:
In-vitro model. Open Nanoscience Journal, 7, 1-7.
http://dx.doi.org/10.2174/1874140101307010001
[8] Perchyonok, V.T., Zhang, S. and Oberholzer, T. (2012)
Alternative chitosan based drug delivery system to fight
oral mucositis: Synergy of conventional and bioactives
towards the optimal solution. Current Nanoscience, 8,
541-547. http://dx.doi.org/10.2174/157341312801784320
[9] Martin, A. (1993) Physical pharmacy. Lea and Febiger,
Philadelphia, London, 496-497.
[10] Chen, S., Liu, M., Jin, S. and Wang, B. (2008) Prepara-
tion of ionic-crosslinked chitosan-based gel beads and
effect of reaction conditions on drug release behaviors.
International Journal of Pharmaceutics, 349, 180-187.
http://dx.doi.org/10.1016/j.ijpharm.2007.08.029
[11] Shin, S.C. and Kim, J.Y. (2000) Enhanced permeation of
triamcinolone acetonide through the buccal mucosa. Euro-
pean Journal of Pharmaceutics and Biopharmaceutics,
50, 217-220.
http://dx.doi.org/10.1016/S0939-6411(00)00101-6
[12] Hamilton-Miller, J.M. (1973) The effect of pH and of
temperature on the stability and bioactivity of nystatin
and amphotericin B. Journal of Pharmacy and Pharma-
cology, 25, 401-407.
h ttp ://dx. doi.org/10.1111/ j.2042-7158.1973.tb10035.x
[13] Perchyonok, V.T., Zhang, S., Grobler, S.R. and Oberhol-
zer, T.G. (2013) Insights into and relative effect of chito-
san-H, chitosan-H-propolis, chitosan-H-propolis-nystatin
and chitosan-H-nystatin on dentine bond strength. Euro-
pean Journal of General Dentistry.
[14] Akala, E.O., Kopecková, P. and Kopecek, J. (1998) No-
vel pH-sensitive hydrogels with adjustable swelling ki-
netics. Biomaterials, 19, 1037-1047.
http://dx.doi.org/10.1016/S0142-9612(98)00023-4
[15] Mura, P., Zerrouk, N., Mennini, N., Maestrelli, F. and
Chemtob, C. (2003) Development and characterization of
naproxen-chitosan solid systems with improved drug dis-
solution properties. European Journal of Pharmaceutical
Sciences, 19, 67-75.
http://dx.doi.org/10.1016/S0928-0987(03)00068-X
[16] De Munck, J., Van Landuyt, J.K., Peumans, M., Poitevin,
A., Lambrechts, P., Braem, M. and Van Meerbeek, B.
(2005) A critical review of the durability of adhesion to
tooth tissue: Methods and results. Journal of Dental Re-
search, 84, 118-132.
http://dx.doi.org/10.1177/154405910508400204
[17] Gan, Q., Wang, T., Cochrane, C. and McCarron, P. (2005)
Modulation of surface charge, particle size and morpho-
logical properties of chitosan-TPP nanoparticles intended
for gene delivery. Colloids and Surfaces B: Biointerfaces,
44, 65-73.
http://dx.doi.org/10.1016/j.colsurfb.2005.06.001
[18] Govender, T., Riley, T., Ehtezazi, T., Garnett, M.C., Stol-
nik, S., Illum, L., et al. (2000) Defining the drug incor-
poration properties of PLA-PEG nanoparticles. Interna-
tional Journal of Pharmaceutics, 199, 95-110.
http://dx.doi.org/10.1016/S0378-5173(00)00375-6
[19] Rokhade, A.P., Shelke, N.B., Patil, S.A. and Aminabhavi,
T.M. (2007) Novel interpenetrating polymer network mi-
crospheres of chitosan and methylcellulose for controlled
release of theophylline. Carbohydrate Polymers, 69, 678-
687. http://dx.doi.org/10.1016/j.carbpol.2007.02.008
[20] Li, X., Li, L., Wang, X., Ren, Y., Zhou, T. and Lu, W.
(2012) Application of model-based methods to character-
ize exenatide-loaded double-walled microspheres: In vivo
release, pharmacokinetic/pharmacodynamic model, and
in vitro and in vivo correlation. Journal of Pharmaceuti-
cal Sciences, 101, 3946-3961.
http://dx.doi.org/10.1002/jps.23236
[21] Tahara, K., Sakai, T., Yamamoto, H., Takeuchi, H., Hira-
shima, N. and Kawashima, Y. (2009) Improved cellular
uptake of chitosan-modified PLGA nanospheres by A549
cells. International Journal of Pharmaceutics, 382, 198-
204. http://dx.doi.org/10.1016/j.ijpharm.2009.07.023
[22] Tahara, K., Sakai, T., Yamamoto, H., Takeuchi, H. and
Kawashima, Y. (2008) Establishing chitosan coated PLGA
nanosphere platform loaded with wide variety of nucleic
acid by complexation with cationic compound for gene
delivery. International Journal of Pharmaceutics, 354,
210-216. http://dx.doi.org/10.1016/j.ijpharm.2007.11.002
[23] Perchyonok, V.T., Zhang, S.M. and Oberholzer, T. (2012)
Towards development of novel chitosan based drug de-
livery prototypes: Devices for targeted delivery drug the-
rapy at the molecular level in aqueous media. Current
Organic Chemistry, 16, 2437-2439.
http://dx.doi.org/10.2174/138527212803520155
[24] Perchyonok, V.T., Zhang, S.M. and Oberholzer, T. (2013)
Chitosan and gelatin based prototype delivery systems for
the treatment of oral mucositis: From material to per-
formance in vitro. Current Drug Delivery, 10, 144-150.
http://dx.doi.org/10.2174/1567201811310010020